Home   Contacts   E-Mail    

    

     

 

History

 Printer symbol
      


D3 Chimie S.A.S.

    
 
1989

Established by Claude Guyand.
First high concentration sulphuric acid storage.
Activity in Port St. Louis du Rhone (PSL).
1993

Start up of the sulphuric acid dilution installation at Lavera (below 70%).
   
1999

HELM France takes a 50% share of D3 Chimie's capital. See www.helmfrance.fr

2001

HELM increases its share of D3 Chimie to 100% and the capital to 918 000 €.
Mr. Michel Joseph Francois becomes the General Manager of D3 Chimie.
   
2005

Closure of the storage and drumming installation in gardanne.
Transfer of the office to Aix-en-Provence.

   
2006
New storage in sulphuric acid in st. Herblain and Bayonne.
   
       
       
HELM AG
   

Ko-helm
Karl Otto Helm

Vorstand
Executive Board
Hermann Schnabel
Hermann Schnabel
   
1900            Karl Otto Helm, a merchant, sets up the company in Hamburg to import and export a wide range of products, including furniture, textile goods, porcelain, fragrances and spices.
 
1950 Hermann Schnabel takes over the company. Success comes quickly due to specialization in chemical trading, business acumen and the creation of a streamlined, modern organization.
 
1960 In the early sixties work starts on expansion abroad, with branch offices in Copenhagen, Madrid and
Mexico, D.F.
 
1970 Turnover reaches 180 million euro, with branch offices in 10 countries, Karl O. Helm company employs 300 people.
 
1978 Karl O. Helm is turned into a family-owned stock corporation called HELM AG.
 
1980 The number of employees doubled to 600, the company has a presence in 20 countries, and with 557 million euro the turnover tripled.
 
1984

Dieter Schnabel becomes chairman of the executive board.

His focus is on:

  • Pushing ahead with the transformation of HELM AG from a trading house into a multifunctional chemical group operating internationally
  • Developing new functions and structures
  • Strengthening the company's international presence

Commencement of methanol production via participation in Trinidad & Tobago.
 

2007 Entry into the biotechnology segment via Richter-Helm BioLogics GmbH & Co. KG.
 
2008 With EURO 9,121 million in turnover, the business year 2008 turned out to be the most successful year in the more than hundred-year history of HELM AG.
2010

A participation in Amarin Technologies S.A., Buenos Aires gives HELM's pharmaceutical division direct access to various generic transdermal products.